The greatest risk reductions in COVID-related and all-cause deaths were seen among women and hospitalized patients.
Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- US flu season shows signs of peak
- Hospitalized COVID patients at higher risk for organ-related death, readmission for 2.5 years, data suggest
- Liberals’, conservatives’ trust in US government’s use of digital health data diverged during COVID
- Report: COVID survivors nearly twice as likely to have ongoing symptoms as those with flu